The U.S. Takes Drastic Steps to Help Charlie Gard

July 19, 2017Jul 19, 2017

On Tuesday, Congresswoman Jaime Herrera Beutler proposed an amendment that would grant Charlie Gard and his parents' permanent residency in the United States so that they could obtain treatment for the 11-month-old.

“Parents have the most at stake when it comes to standing up for their children and right now, we have an incredible opportunity to stand with a family and save a child’s life,” said Herrera Beutler in a statement.

She continued, “This amendment would speed up the process, cut through the bureaucratic red tape, and ease the path for Charlie to be able to receive medical treatment in the U.S. that his parents and medical specialists believe is worth pursuing.”

In 2013, Beutler had her own miracle baby. Doctors told her she should abort her unborn baby girl, who had Potter’s Syndrome. Beutler refused; instead, she pushed for an experimental treatment that allowed her baby to come to term without any kidneys.

The U.S. House Appropriations Committee voted unanimously to pass the amendment. CNN reports that the amendment, which was added to the controversial Homeland Security bill, will have to be voted on in the full House and the Senate before it becomes law. However, The Hill is reporting that the amendment has passed into law. It is currently unclear who is reporting correctly.

Currently, U.S neurologist Michio Hirano, the Columbia doctor who developed the experimental treatment, is in London examining Charlie. His testimony will be presented to Justice Francis, who will decide on July 25th, if Charlie will be allowed by the U.K. government to receive treatment.

Pray for Charlie and that things will work out in his favor.

RELATED STORY: President Trump Isn't Ready to Give Up on Charlie Gard

RELATED STORY: Pope Francis Considering Giving Charlie Gard Vatican Citizenship Says Source

RELATED STORY: CNN Had Something Positive to Say About This Pro-Life Woman

Next: CNN Had Something Positive to Say About This Pro-Life Woman Jun 20, 2017